AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JOST Werke AG

Investor Presentation Nov 21, 2019

237_ip_2019-11-21_58d6f661-7fc3-447e-812b-2fd4281b31b5.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

Results 9M 2019

Joachim Dürr (CEO) Dr. Christian Terlinde (CFO)

JOST Werke AG – November 21, 2019

1. Highlights – 9M 2019

  • 2. Market outlook
  • 3. Detailed results review
  • 4. Company outlook
  • 5. Q&A

s
e
al
S
+1.9% to
€579m
Markets slowed down in Q3; group
sales in 9M up
were down by -2.3%
to €343m in 9M, despite strong decline of trailer
JOST's sales in Europe
markets
continued with strong momentum +20.9% to
€129m in 9M
North America
down -3.1% to €107m affected by very weak Indian market. JOST could
Sales in APA
increase prior year's sales in the other countries of the region despite overall declining markets
s
g
n
ni
r
a
E
+0.4% to €66m in 9M
Adjusted EBIT
in 9M nearly stable at 11.3%
Adjusted EBIT margin
e
c
n
a
n
Fi
Operating cash flow doubled to €56m due to significant improvements in working capital
Net Working Capital as % of LTM sales down by 2.5pp to 19.5%
Outlook JOST expects sales and earnings in 2019 to decline in a low-single-digit percentage range
compared to 2018

Agenda

1. Highlights – 9M 2019

  • 2. Market outlook
  • 3. Detailed results review
  • 4. Company outlook

5. Q&A

Truck and trailer market outlook for 2019

Note: Market estimates for heavy truck based on LMC, Clear Consulting and FTR (as of October 2019)

Agenda

1. Highlights – 9M 2019

  • 2. Market outlook
  • 3. Detailed results review
  • 4. Company outlook

5. Q&A

  • ❖ Continued high activity level in North America partially offset weakness of markets in Europe and India during Q3
  • ❖ In 9M 2019 group sales up by +1.9%
  • ❖ Adj. EBIT developed mostly in line with sales, with Q3 adj. EBIT down by 6.6% and margin stable at 10.7%
  • ❖ In 9M adj. EBIT grew by 0.4% with margin reaching 11.3%
  • ❖ Good operating performance in North America partially offset cost pressure from increasing wages in other regions

¹ Reported sales figures do not include sales of Brazil JV

  • ❖ Typical Q3 seasonality in Europe was stronger than in prior years, but sales remained on a high level with Q3 19 being the second strongest JOST's Q3 in the region.
  • ❖ Market impact: Trailer production in Europe declined further and truck production was weaker compared to strong prior year. Sales to specialty trailers remained stable
  • ❖ Adj. EBIT and adj. EBIT margin below prior year mostly due to:
    • lower sales volume
    • rising personnel costs
  • ❖ Focus for the remainder of 2019 and the following year are:
    • further increase of efficiency across all processes
    • increasing automation in the production area

  • ❖ JOST continued its growth in North America, with sales up by +20.9% in 9M and +6.8% in Q3
  • ❖ Reported sales grew stronger than organic sales due to FX-tailwinds of 4.7% in Q3 and 7.1% in 9M
  • ❖ Market impact: JOST continued to profit from strong demand, strengthening its market position
  • ❖ Adj. EBIT up by +24.6% in 9M with adj. EBIT margin increasing to 9.4%
  • ❖ Adj. EBIT margin in Q3 reached the double-digit range at 10.0% for the 2nd consecutive quarter.
  • ❖ Margin improvement supported by strong sales growth and good operating performance

APA – Ongoing weakness in India affects APA results

  • ❖ Sales in APA were down by 17% in Q3, mostly due to strong decline of truck and trailer demand in India
  • ❖ In 9M sales only down by 3.1% due to good performance of JOST in China and other APA countries
  • ❖ Market impact: In Q3 JOST was able to keep sales on prior year's level in most APA countries, but this was not enough to compensate the strong decline in India.
  • ❖ Adj. EBIT down mostly in line with sales development with margins reaching 14.2% in 9M.
  • ❖ Margins in Q3 improved to 14.6% despite declining sales. JOST was able to use its flexibility to scale down production levels in India and cut costs quickly, reducing negative impact for the region

Adjusted net income and adjusted EPS increased in 9M 2019

  • ❖ Adjustments to EBIT mainly from amortization of PPA (non-operating)
  • ❖ Although EBT grew by 12.9% to €41.2 m (9M 2018: €36.5m), reported net earnings declined to €34.4m (9M 2018: €43.3m) due to a positive one-off tax effect in the previous year amounting to €14.8m. Accordingly EPS in 9M 2019 amounted to €2.31 (9M 2018: €2.91).
  • ❖ Adjusted net income grew by 3.1% to €42.7m (9M 2018: €41.5m). Adjusted EPS grew to €2.87 (9M 2018: €2.78).

1 Cash flow defined as adjusted EBITDA – capex; cash conversion defined as (adjusted EBITDA – capex)/adjusted EBITDA

2 Capex calculated as payments to acquire property, plant and equipment as well as intangible assets

❖ Cash conversion rate rose as a result of higher operating earnings and better working capital management

Key highlights

  • ❖ Capex in 9M 2019 lower than in prior year due to different phasing of investments
  • ❖ Higher portion of investment should take place in Q4, with FY capex expected to be ~2.5% of sales
  • ❖ Working capital improved primarily due to lower trade receivables and higher trade payables
  • ❖ NWC as % of sales improved to 19.5%
  • ❖ By year end NWC is expected to improve further and fall below prior year's level (2018: 18.5%) – previously JOST was expecting NWC to be at ~20%

Key highlights

  • ❖ ROCE only slightly down to 19.2% despite increase of other financial liabilities following the first-time adoption of IFRS 16
  • ❖ Equity ratio increased compared to year end, despite negative impact from the first-time adoption of IFRS 16, which resulted in an increase of short- and long-term financial liabilities, and dividend payments of €16.4m.

❖ Leverage improved to 0.57x

  • ❖ Liquid assets grew by €25.5m reaching €91.6m
  • ❖ Net debt was further reduced to €59.6m because of the strong increase in liquid assets

1 ROCE=LTM adj. EBIT / interest-bearing capital employed (interest-bearing capital: equity + financial liabilities (excl. refinancing costs) – liquid assets + provisions for pensions) 2 Net debt = Interest-bearing capital (excl. refinancing costs) – liquid assets

3 Leverage = Net debt/LTM adj. EBITDA [LTM EBITDA 9M 2019= €104m; EBITDA FY 2018 = €100m]

Agenda

1. Highlights – 9M 2019

  • 2. Market outlook
  • 3. Detailed results review
  • 4. Company outlook
  • 5. Q&A

Outlook for FY 2019

FY 2018 Outlook 2019 (old)1 Outlook 2019 (new)
Sales 755 Low-single-digit % growth Low-single-digit % decline
Adjusted
EBITDA
100 Low-single-digit % growth Low-single-digit % decline
Adjusted
EBIT
81 Low-single-digit % growth Low-single-digit % decline
Adjusted
EBIT
margin
10.7% Stable ~ Stable
Capex2
(in
%
of
sales)
20
(2.6%)
~2.5% of sales ~2.5% of sales
Net
working
capital
(in
%
of
sales)
140
(18.5%)
<20% <18.5%
Leverage3 0.85x <0.85x ~0.5x

1 The previous outlook was based on the assumption of a stable macroeconomic and political environment in 2019

2 Capex calculated as payments to acquire property, plant and equipment as well as intangible assets, excluding potential acquisitions

3 Excluding potential acquisitions

Agenda

1. Highlights – 9M 2019

  • 2. Market outlook
  • 3. Detailed results review
  • 4. Company outlook

5. Q&A

Development of JOST's sales and adjusted EBIT by quarter

Shareholder structure

Shareholder structure as of November 15, 2019

  • Allianz Global Investors
  • Atlantic Value
  • Morgan Stanley
  • Paradice Investment Management
  • Virtus Investment Partners
  • FMR LLC
  • Management Board

Other

1 According to German stock exchange definition 100% of shares qualify as free float

Key figures – 9M 2019 and Q3 2019

(€ m) 9M 2019 9M 2018 yoy Q3 2019 Q3 2018 yoy
Sales
Europe
343.0 351.0 -2.3 % 102.6 108.2 -5.1%
Sales North America 129.3 106.9 20.9 % 43.3 40.6 6.8%
Sales APA 106.8 110.2 -3.1 % 31.9 38.3 -16.6%
Sales JOST Werke Group 579.1 568.1 1.9 % 177.8 187.0 -4.9%
EBITDA1
Adjusted
83.2 78.8 5.6 % 24.9 24.8 0.2%
Adjusted
EBITDA
margin
14.4 % 13.9% 0.5 pp 14.0 % 13.3 % 0.7 pp
EBIT1
Adjusted
65.5 65.3 0.4 % 19.0 20.3 -6.6 %
Adjusted
EBIT
margin
11.3 % 11.5 % -0.2 pp 10.7 % 10.8 % -0.1 pp
Adjusted
net
income1
42.7 41.5 3.1 % 12.8 12.6 1.5 %
Adjusted
EPS
(€)
2.87 2.78 3.2 % 0.86 0.85 1.2 %
Capex 11.1 14.2 -22.0 % 4.1 5.0 -18.1 %
Capex
(%
of
sales)
1.9 % 2.5 % -0.6 pp 2.3 % 2.7 % -0.4 pp
ROCE2 19.2 % 18.9 % 0.3 pp
rate3
Cash
conversion
86.7 % 82.0 % 4.7 pp 83.5% 79.8% 3.7 pp
ratio4
Leverage
0.57x 1.16x -50.4 %

1Adjusted for PPA effects and exceptionals

2LTM adj. EBIT/ interest-bearing capital employed; interest-bearing capital: shareholders' equity + financial liabilities excl. refinancing costs – liquid assets + provisions for pensions

3(Adj. EBITDA – Capex) / adj. EBITDA

4 Net debt / LTM adj. EBITDA

Reconciliation of earnings

(€m) 9M 2019
reported
Other
Effects
PPA Total
adjustments
9M 2019
adjusted
Sales revenues 579.1 579.0
Cost of sale -428.4 0.2 0.2 -428.2
Gross profit 150.7 0.2 0.2 150.9
Selling expenses -66.8 0.2 18.8 19.0 -47.8
R&D expenses -10.3 -10.3
Administrative expenses -31.3 0.6 0.6 -30.7
Other income / -expenses 0.6 0.1 0.1 0.7
Share of JV profit 2.7 2.7
Operating profit (EBIT) 45.6 1.1 18.8 19.9 65.5
Net finance result -4.5 -4.5
Profit / loss before tax 41.1 0 18.8 19.9 61.0
Income taxes -6.7 -18.3
Profit / loss after taxes 34.4 42.7
Number of shares 14,900,000 14,900,000
EPS (in €) 2.31 2.87

Further information

Financial Calendar 2019

Nov. 21 Publication of 9M 2019 Report

Nov. 22 Road show London, UK

Jan. 10 ODDO
BHF Forum 2020, Lyon/France
Jan. 13-15 Commerzbank German Investment Seminar 2020,
New York/U.S.
Jan. 21 UniCredit & Kepler Cheuvreux,
19. German Corporate Conference, Frankfurt/Germany
Feb. 18 Preliminary Results FY 2019
Mar. 25 Publication of Annual Group Report FY 2019
May 7 Annual General Meeting 2020
May 14 Publication of Q1 2020 Report
Aug. 13 Publication of H1 2020 Report
Nov. 12 Publication of 9M 2020 Report

IR Contact

Romy Acosta Senior Manager Investor Relations

[email protected] Phone: +49-6102-295 379 Financial Calendar 2020 Fax: +49-6102-295 661

Disclaimer

THIS PRESENTATION IS CONFIDENTIAL AND MUST NOT BE RELEASED, PUBLISHED, TRANSMITTED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION WHERE SUCH DISTRIBUTION IS UNLAWFUL.

This presentation (the "Presentation") was specifically prepared by JOST Werke AG (the "Company") for informational purposes only. It is intended to provide a general overview of the Company's business and does not purport to include all aspects and details regarding the Company. This Presentation must not be reproduced in any form, passed on or otherwise made available, directly or indirectly, to any other person, or published or otherwise disclosed, in whole or in part, for any purpose, without prior written consent by the Company. Neither the Company nor any of its directors, officers, employees or advisors, nor any other person makes any representation or warranty, express or implied, as to, and accordingly no reliance should be placed on, the fairness, accuracy or completeness of the information contained in the Presentation or of the views given or implied. Neither the Company nor any of its respective directors, officers, employees or advisors nor any other person shall have any liability whatsoever for any errors or omissions or any loss howsoever arising, directly or indirectly, from any use of this information or its contents or otherwise arising in connection therewith.

This Presentation is neither an advertisement nor a prospectus and does not, and is not intended to, constitute or form part of, and should not be construed as, an offer to sell, or a solicitation, invitation or inducement to purchase, subscribe for, underwrite or otherwise acquire any securities of the Company, nor should it, or any part of it, form the basis of or be relied on in connection with or act as any inducement to enter into any contract to purchase or subscribe for any securities of the Company, nor shall it, or any part of it, form the basis of or be relied on in connection with any contract or commitment or investment decision whatsoever. This Presentation and the information and opinions contained therein are selective in nature and do not purport to contain all information that may be required to evaluate the Company and/or its shares. The information and opinions contained in this Presentation are provided as of the date of this Presentation and may be subject to updating, revision, amendment or change without notice. Neither the Company nor any of its directors, officers, employees or advisors are under any obligation to update or keep current the information contained in this Presentation or to correct any inaccuracies in any such information which may become apparent or to provide any additional information whether as a result of new information, future events or otherwise.

This Presentation contains forward-looking statements relating to matters that are not historical facts. These statements reflect the Company's current knowledge, intentions and beliefs as well as its current expectations and projections about future events, including the Company's prospects, growth, strategies, the industry in which it operates and potential or ongoing acquisitions. Forward-looking statements can be identified by the context of such statements or words such as "anticipate," "believe", "estimate", "expect", "forecast", "intend", "plan", "project", "target", "may", "will", "would", "could" or "should" or similar terminology. By their nature, forward-looking statements are subject to a number of risks, uncertainties and assumptions, many of which are beyond the Company's control, that could cause the Company's actual results and performance to differ materially from and adversely affect any expected future results or performance expressed or implied by any forward-looking statements as a result of various factors (including global economic conditions, changed market conditions, competition, costs of compliance, changing political, legal, economic and other conditions). Forward-looking statements should not therefore be read as guarantees of future performance or results and will not necessarily be accurate indications of whether or not such results will be achieved. Similarly, past performance should not be taken as an indication of future results, and no representation or warranty, express or implied, is made regarding future performance. In addition, even if the development of the Company's prospects, growth, strategies and the industry in which it operates are consistent with the forward-looking statements contained in this Presentation or past performance, those developments may not be indicative of the Company's results, liquidity or financial position or of results or developments in subsequent periods not covered by this Presentation. The Company undertakes no obligation to release the results of any revisions to any forward-looking statements in this Presentation that may occur due to any change in its expectations or to reflect events or circumstances after the date of this Presentation.

To the extent available, the industry and market data contained in this Presentation is derived from third-party sources. Third-party industry publications, studies and surveys generally state that the data contained therein have been obtained from sources believed to be reliable, but that there is no guarantee of the accuracy or completeness of such data. In addition, certain information in this Presentation is selective and may not necessarily be representative for the Company. Further, some of the industry and market data contained in this Presentation is derived from the Company's own internal research and estimates based on the knowledge and experience of the Company's management in the market in which the Company operates. While the Company believes that such research and estimates are reasonable and reliable, they, and their underlying methodology and assumptions, have not been verified by any independent source for accuracy or completeness and are subject to change without notice. Accordingly, no reliance should be placed on the industry or market data contained in this Presentation.

Subject to limited exceptions described below, the information contained in this Presentation is not to be released, published, transmitted or distributed within or into the United States of America ("United States"), Australia, Canada or Japan and does not constitute an offer of securities for sale in any of these jurisdictions. Any securities offered by the Company have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any state or other jurisdiction of the United States and such securities may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state or local securities laws. This Presentation does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities to any person or in any jurisdiction to whom or in which such offer or solicitation is unlawful. Any failure to comply with these restrictions may constitute a violation of applicable securities laws.

Talk to a Data Expert

Have a question? We'll get back to you promptly.